Metabolic dysfunction-associated fatty liver disease on distinct microbial communities at the bacterial phylum level.

BACKGROUND: Limited data are available on the correlation between microbial communities and metabolic dysfunction-associated fatty liver disease (MAFLD).

OBJECTIVE: This study aimed to evaluate the influence of MAFLD on distinct microbial communities.

METHODS: We recruited 43 patients with a nonviral liver disease. Enrolled patients were divided into two groups according to MAFLD criteria. The fecal microbial composition was evaluated using the variable V3-V4 region of the 16S ribosomal RNA region, which was amplified using polymerase chain reaction. First, we assessed the influence of MAFLD on distinct microbial communities at the bacterial phylum level. Next, the correlation between the microbial communities and diversity in patients with MAFLD was evaluated.

RESULTS: Among the enrolled participants, the non-MAFLD and MAFLD groups consisted of 21 and 22 patients, respectively. Sequences were distributed among ten bacterial phyla. The relative abundance of Firmicutes was significantly higher in the MAFLD group than in the non-MAFLD group (p=0.014). The microbial diversity was not significantly influenced by the presence of MAFLD (Chao index: p = 0.215 and Shannon index p = 0.174, respectively), though the correlation coefficient between the abundances of Firmicutes and microbial diversity was higher in the non-MAFLD group than in the MAFLD group.

CONCLUSION: The presence of MAFLD increased the relative abundances of Firmicutes at the bacterial phylum level, which may cause the discrepancy between the abundances of Firmicutes and diversity in patients with MAFLD.